KP
MDT icon

Kiltearn Partners’s Medtronic MDT Stock Holding History

Kiltearn Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13M Sell
149,561
-31,200
-17% -$2.99M 3.49% 14
2025
Q4 		$17.4M Sell
180,761
-35,800
-17% -$3.48M 3.76% 8
2025
Q3 		$20.6M Sell
216,561
-16,200
-7% -$1.49M 4.13% 8
2025
Q2 		$20.3M Sell
232,761
-18,800
-7% -$1.59M 4.08% 9
2025
Q1 		$22.6M Sell
251,561
-44,700
-15% -$4M 4.31% 9
2024
Q4 		$23.7M Sell
296,261
-31,600
-10% -$2.74M 3.91% 8
2024
Q3 		$29.5M Sell
327,861
-31,900
-9% -$2.68M 4.01% 11
2024
Q2 		$28.3M Buy
359,761
+25,900
+8% +$2.12M 3.43% 11
2024
Q1 		$29.1M Sell
333,861
-62,200
-16% -$5.31M 2.69% 15
2023
Q4 		$32.6M Buy
396,061
+154,961
+64% +$11.8M 2.51% 17
2023
Q3 		$18.9M Sell
241,100
-8,400
-3% -$703K 1.49% 28
2023
Q2 		$22M Sell
249,500
-7,500
-3% -$646K 1.61% 26
2023
Q1 		$20.7M Buy
257,000
+61,500
+31% +$5.01M 1.5% 27
2022
Q4 		$15.2M Buy
+195,500
New +$15.8M 1.12% 30

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kiltearn Partners's MDT Position: Q1 2026 in Review

Kiltearn Partners reduced its Medtronic (MDT) stake by 17% in Q1 2026, selling an estimated $2.99M and leaving 149,561 shares worth $13M. The position accounts for 3.49% of the portfolio, ranked #14.

Kiltearn Partners first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $32.6M in Q4 2023. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kiltearn Partners held 149,561 shares of Medtronic worth $13M as of Q1 2026.
  • Kiltearn Partners sold 31,200 Medtronic shares in Q1 2026, an estimated $2.99M.
  • Medtronic made up 3.49% of Kiltearn Partners's portfolio in Q1 2026, its #14 holding.
  • Kiltearn Partners first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • Kiltearn Partners's Medtronic position peaked at $32.6M in Q4 2023.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kiltearn Partners's 13F filing for Q1 2026, filed 14 May 2026.